Transformation from the NSCLC to SCLC usually causes strong drug resistance due to cell plasticity.248 SCLC cells often lose EGFR expression; therefore, they are resistant to EGFR inhibitors, in contrast to the nontransformed NSCLC (specifically LUAD). This evidence concerns the gene EGFR and small cell lung carcinoma.